28-May-2019 - Biotage AB

Tomas Blomquist: New CEO & President of Biotage

Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employees. Tomas Blomquist has been in the Life Sciences industry for a long time and comes with sales and management experiences from Alere, Analyticon, Johnson & Johnson and Roche.

Facts, background information, dossiers
  • Tomas Blomquist
  • appointments
More about Biotage